Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Amortization - Intangibles of $11.8 million for Q2 2026, up 191.58% year-over-year from $4.1 million in Q2 2025, and up 2.25% quarter-over-quarter from $11.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2026) Analysis & Trends
Ptc Therapeutics' Amortization - Intangibles history runs 10 years deep, the most recent figure standing at $11.8 million for Q2 2026.
- In Q2 2026, Amortization - Intangibles rose 191.58% year-over-year to $11.8 million; the TTM figure through Jun 2026 stood at $40.3 million (up 183.8% YoY), while the FY2025 annual figure was $24.7 million, down 59.26% from the prior year.
- Amortization - Intangibles for Q2 2026 stood at $11.8 million, up from $11.6 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $77.2 million in Q4 2023, with the low at $2.9 million in Q2 2024.
- The 5-year median for Amortization - Intangibles is $17.7 million (2022), against an average of $24.9 million.
- The sharpest annual moves came in 2024 and 2026: Amortization - Intangibles tumbled 95.71% in 2024, then surged 204.92% in 2026.
- Ptc Therapeutics' Amortization - Intangibles stood at $35.8 million in 2022, then surged by 115.51% to $77.2 million in 2023, then sank by 95.71% to $3.3 million in 2024, then jumped by 182.7% to $9.3 million in 2025, then increased by 26.66% to $11.8 million in 2026.
- Business Quant data shows PTCT's Amortization - Intangibles at $11.8 million in Q2 2026, $11.6 million in Q1 2026, and $9.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.84 Mn |
| Mar 31, 2026 | 11.58 Mn |
| Dec 31, 2025 | 9.35 Mn |
| Sep 30, 2025 | 7.53 Mn |
| Jun 30, 2025 | 4.06 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 51.53 Mn |
| Dec 31, 2023 | 77.17 Mn |
| Sep 30, 2023 | 58.65 Mn |
| Jun 30, 2023 | 47.40 Mn |
| Mar 31, 2023 | 39.42 Mn |
| Dec 31, 2022 | 35.76 Mn |
| Sep 30, 2022 | 31.02 Mn |
| Jun 30, 2022 | 26.29 Mn |
| Mar 31, 2022 | 23.50 Mn |
| Dec 31, 2021 | 16.35 Mn |
| Sep 30, 2021 | 14.40 Mn |